InvestorsHub Logo
Followers 36
Posts 1166
Boards Moderated 0
Alias Born 03/07/2013

Re: None

Thursday, 07/07/2016 9:38:27 PM

Thursday, July 07, 2016 9:38:27 PM

Post# of 118384
If anyone needs the URL for GM's notice (thanks by the way) of the CIM agreement, here it is: 8-K 7/7/2016

With a $12,500 retainer fee upon signing and the $10,000/month retainer fee for the other firm negotiating deals for the product line, one thing seems clear to me: RGBP truly believes its science and new discoveries are at a point advanced enough to engage others in striking deals, whether that is with Mexico and the HemaX clinical trials (which now have 3 month data on other blood applications testing) as well as the development for aplastic anemia and/or the NR2F6 small molecule research advancement which now has at least 2 matches for activation.

July - August should bring some very interesting news. Any agreement that is reasonable and gives the company enough cash for clinical phase I trials should have a positive effect on PPS as well.

Let's hope all goes well.